Solved

Guidance for the Development of a Selective-Reporting or Cascade-Reporting Protocol

Question 66

Multiple Choice

Guidance for the development of a selective-reporting or cascade-reporting protocol for antibiotics is available from the


A) Centers for Disease Control and Prevention (CDC) .
B) Clinical Laboratory and Standards Institute (CLSI) .
C) United States Army Medical Research Institute (USAMRIID) .
D) Food and Drug Administration (FDA) .

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Q61: Important factors that must be considered when

Q62: Oxacillin-resistant Staphylococcus aureus is called<br>A) methicillin-resistant S.

Q63: In this type of antimicrobial susceptibility test,

Q64: How are antibiotics chosen for inclusion into

Q65: Quality control of antimicrobial susceptibility tests involves<br>A)

Q67: On what media is Kirby-Bauer testing performed

Q68: Goals of combination antimicrobial therapy include all

Q69: Agar dilution and disk diffusion tests for

Q70: When would it be appropriate for an

Q71: What is the most widely used